ESR1 and neoplasm: Survival analysis of GATA3 in the present study demonstrated similar results that over-expression of GATA3 was associated with better survival in patients with breast cancer, particularly in patients with ER positive or luminal subtype breast cancer, suggesting the tumor-suppressive role of GATA3 in hormone sensitive breast cancer.